Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Gilead Sciences, Inc. (GILD) has a Wall Street consensus price target of $157.38, based on estimates from 58 covering analysts. With the stock currently trading at $148.95, this represents a potential upside of +5.7%. The company has a market capitalization of $185.59B.
Analyst price targets range from a low of $105.00 to a high of $177.00, representing a 46% spread in expectations. The median target of $161.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 38 analysts rating the stock as a Buy or Strong Buy,19 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, GILD trades at a trailing P/E of 392.0x and forward P/E of 17.1x. Analysts expect EPS to grow +28.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $148.95, with bear and bull scenarios of $15.35 and $152.26 respectively. Model confidence stands at 46/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how GILD stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus price target for GILD is $157.38, close to the current price of $148.95 (5.7% implied move). Based on 58 analyst estimates, the stock appears fairly valued near current levels.
GILD has a consensus rating of "Buy" based on 58 Wall Street analysts. The rating breakdown is predominantly bullish, with 38 Buy/Strong Buy ratings. The consensus 12-month price target of $157.38 implies 5.7% upside from current levels.
With a forward P/E of 17.1315x, GILD trades at a relatively low valuation. The consensus target of $157.38 implies 5.7% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $177 for GILD, while the most conservative target is $105. The consensus of $157.38 represents the median expectation. Our quantitative valuation model projects a bull case target of $152 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
GILD is heavily covered by Wall Street, with 58 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 38 have Buy ratings, 19 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month GILD stock forecast based on 58 Wall Street analysts shows a consensus price target of $157.38, with estimates ranging from $105 (bear case) to $177 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $149, with bear/bull scenarios of $15/$152.
Our quantitative valuation model calculates GILD's fair value at $149 (base case), with a bear case of $15 and bull case of $152. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.
GILD trades at a forward P/E ratio of 17.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 392.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
GILD appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $157.38 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
GILD analyst price targets range from $105 to $177, a 46% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $157.38 consensus represents the middle ground. Our model's $15-$152 range provides an independent fundamental perspective.